New ETF (HRTS) Tracks Developers of Obesity Drugs Amid Ozempic Hype - Bloomberg

Forget Ozempic. Eli Lilly's New Weight-Loss Drug Is Astonishing. - Bloomberg

Maurits Pot on LinkedIn: CANC

Watch Bloomberg Markets: The Close 11/27/2023 - Bloomberg

coreplusdisplay1.png

M on X: New ETF Tracks Developers of Obesity Drugs Amid Ozempic Hype / X

A New Ozempic-Inspired ETF Is Hitting the Stock Market

Ozempic's Surging Popularity Has Novo Nordisk (NVO) Struggling to Meet Demand - Bloomberg

The Year Ozempic, Wegovy and More Weight-Loss Drugs Ate the News - Bloomberg

Who Can Access Weight-Loss Drugs Like Ozempic, Wegovy, Mounjaro - Bloomberg